$HSTM
HEALTHSTREAM INC

2021 Q1 Form 10-Q Financial Statement

#000156459021022023 Filed on April 29, 2021

View on sec.gov

Income Statement

Concept 2021 Q1 2020 Q1
Revenue $63.47M $61.57M
YoY Change 3.08% -5.55%
Cost Of Revenue $21.24M $20.36M
YoY Change 4.32% -24.2%
Gross Profit $42.23M $41.21M
YoY Change 2.48% 7.52%
Gross Profit Margin 66.54% 66.93%
Selling, General & Admin $20.42M $19.05M
YoY Change 7.19% -2.26%
% of Gross Profit 48.35% 46.23%
Research & Development $9.525M $7.468M
YoY Change 27.54% 7.81%
% of Gross Profit 22.56% 18.12%
Depreciation & Amortization $9.153M $7.449M
YoY Change 22.88% 13.92%
% of Gross Profit 21.67% 18.08%
Operating Expenses $9.525M $7.468M
YoY Change 27.54% 7.81%
Operating Profit $3.300M $7.244M
YoY Change -54.45% 34.92%
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net -$87.00K $1.710M
YoY Change -105.09% 108.03%
Pretax Income $3.213M $8.950M
YoY Change -64.1% 44.56%
Income Tax $922.0K $1.900M
% Of Pretax Income 28.7% 21.23%
Net Earnings $2.291M $7.092M
YoY Change -67.7% 18.71%
Net Earnings / Revenue 3.61% 11.52%
Basic Earnings Per Share $0.07 $0.22
Diluted Earnings Per Share $0.07 $0.22
COMMON SHARES
Basic Shares Outstanding 31.50M 32.33M
Diluted Shares Outstanding 31.53M 32.36M

Balance Sheet

Concept 2021 Q1 2020 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $55.97M $142.0M
YoY Change -60.58% -3.36%
Cash & Equivalents $45.35M $107.4M
Short-Term Investments $10.62M $34.60M
Other Short-Term Assets $21.80M $23.90M
YoY Change -8.79% -33.98%
Inventory
Prepaid Expenses
Receivables $37.20M $34.80M
Other Receivables $0.00 $0.00
Total Short-Term Assets $115.0M $200.7M
YoY Change -42.7% -10.28%
LONG-TERM ASSETS
Property, Plant & Equipment $47.90M $53.60M
YoY Change -10.63% -3.25%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $7.800M $4.300M
YoY Change 81.4% 207.14%
Other Assets $24.30M $18.10M
YoY Change 34.25% 2034.43%
Total Long-Term Assets $386.7M $280.8M
YoY Change 37.7% 8.09%
TOTAL ASSETS
Total Short-Term Assets $115.0M $200.7M
Total Long-Term Assets $386.7M $280.8M
Total Assets $501.7M $481.5M
YoY Change 4.19% -0.41%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $20.00M $16.40M
YoY Change 21.95% -8.89%
Accrued Expenses $8.500M $13.70M
YoY Change -37.96% -32.84%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $116.9M $102.5M
YoY Change 14.05% -7.66%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities $31.40M $357.0K
YoY Change 8695.52% -42.05%
Total Long-Term Liabilities $31.40M $357.0K
YoY Change 8695.52% -42.05%
TOTAL LIABILITIES
Total Short-Term Liabilities $116.9M $102.5M
Total Long-Term Liabilities $31.40M $357.0K
Total Liabilities $164.9M $146.1M
YoY Change 12.87% -7.77%
SHAREHOLDERS EQUITY
Retained Earnings $55.24M
YoY Change
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $336.8M $335.4M
YoY Change
Total Liabilities & Shareholders Equity $501.7M $481.5M
YoY Change 4.19% -0.41%

Cashflow Statement

Concept 2021 Q1 2020 Q1
OPERATING ACTIVITIES
Net Income $2.291M $7.092M
YoY Change -67.7% 18.71%
Depreciation, Depletion And Amortization $9.153M $7.449M
YoY Change 22.88% 13.92%
Cash From Operating Activities $19.10M $6.116M
YoY Change 212.36% -61.98%
INVESTING ACTIVITIES
Capital Expenditures $1.898M $1.010M
YoY Change 87.92% -91.09%
Acquisitions $731.0K $21.42M
YoY Change -96.59% 18.99%
Other Investing Activities -$2.440M -$14.83M
YoY Change -83.55% -35.83%
Cash From Investing Activities -$9.660M -$19.90M
YoY Change -51.47% -49.46%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $0.00 $9.876M
YoY Change -100.0%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -$411.0K -10.28M
YoY Change -96.0% 2364.99%
NET CHANGE
Cash From Operating Activities $19.10M 6.116M
Cash From Investing Activities -$9.660M -19.90M
Cash From Financing Activities -$411.0K -10.28M
Net Change In Cash $8.782M -24.11M
YoY Change -136.42% 1.7%
FREE CASH FLOW
Cash From Operating Activities $19.10M $6.116M
Capital Expenditures $1.898M $1.010M
Free Cash Flow $17.21M $5.106M
YoY Change 236.98% 7.56%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2021Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.07
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
2291000
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
7092000
CY2021Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.07
CY2020Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.22
CY2020Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.22
CY2021Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
31504000
CY2020Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
32334000
CY2021Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
31526000
CY2020Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
32357000
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
2291000
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
7092000
CY2021Q1 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
230000
CY2020Q1 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-44000
CY2021Q1 us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
4000
CY2020Q1 us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
-101000
CY2020Q1 us-gaap Increase Decrease In Royalties Payable
IncreaseDecreaseInRoyaltiesPayable
442000
CY2021Q1 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
6862000
CY2020Q1 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
6453000
CY2020Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
6116000
CY2021Q1 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
76000
CY2020Q1 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-134000
CY2021Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-5339000
CY2020Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-5775000
CY2021Q1 us-gaap Increase Decrease In Royalties Payable
IncreaseDecreaseInRoyaltiesPayable
-305000
CY2021Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
234000
CY2020Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-145000
CY2021Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
2525000
CY2020Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
6947000
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
334062000
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
2291000
CY2021Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
616000
CY2021Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
-399000
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
338168000
CY2020Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
550000
CY2020Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
-373000
CY2020Q1 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
9876000
CY2020Q1 us-gaap Stockholders Equity
StockholdersEquity
335416000
CY2021Q1 us-gaap Profit Loss
ProfitLoss
2291000
CY2020Q1 us-gaap Profit Loss
ProfitLoss
7092000
CY2020Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
7449000
CY2020Q1 us-gaap Share Based Compensation
ShareBasedCompensation
550000
CY2020Q1 us-gaap Amortization Of Deferred Sales Commissions
AmortizationOfDeferredSalesCommissions
2159000
CY2020Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
288000
CY2020Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
500000
CY2021Q1 hstm Gain Loss On Non Marketable Equity Investments
GainLossOnNonMarketableEquityInvestments
-54000
CY2020Q1 hstm Gain Loss On Non Marketable Equity Investments
GainLossOnNonMarketableEquityInvestments
-11000
CY2021Q1 hstm Non Cash Paid Time Off Expense
NonCashPaidTimeOffExpense
-1011000
CY2020Q1 hstm Non Cash Royalty Expense
NonCashRoyaltyExpense
-3440000
CY2020Q1 hstm Change In Fair Value Of Non Marketable Equity Investments
ChangeInFairValueOfNonMarketableEquityInvestments
-1152000
CY2021Q1 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-15000
CY2020Q1 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-47000
CY2021Q1 us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
-7379000
CY2020Q1 us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
4573000
CY2021Q1 us-gaap Increase Decrease In Prepaid Royalties
IncreaseDecreaseInPrepaidRoyalties
2215000
CY2020Q1 us-gaap Increase Decrease In Prepaid Royalties
IncreaseDecreaseInPrepaidRoyalties
3202000
CY2021Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-2521000
CY2020Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-735000
CY2021Q1 hstm Increase Decrease In Deferred Commissions
IncreaseDecreaseInDeferredCommissions
3602000
CY2020Q1 hstm Increase Decrease In Deferred Commissions
IncreaseDecreaseInDeferredCommissions
1602000
CY2020Q1 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
21421000
CY2020Q1 us-gaap Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
20725000
CY2021Q1 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
731000
CY2021Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
63468000
CY2020Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
61572000
CY2021Q1 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
33600000
CY2020Q1 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
31600000
CY2020Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-10279000
CY2021Q1 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-251000
CY2020Q1 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-46000
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
8782000
CY2020Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-24113000
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
36566000
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
131538000
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
45348000
CY2021Q1 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
446000000
CY2021Q1 us-gaap Revenue Remaining Performance Obligation Percentage
RevenueRemainingPerformanceObligationPercentage
0.46
CY2021Q1 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P12M
CY2021Q1 hstm Description Of Sales Commission Plan
DescriptionOfSalesCommissionPlan
Sales commissions earned by our sales force are considered incremental and recoverable costs of obtaining a contract with a customer.
CY2020Q1 us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
14130000
CY2021Q1 hstm Payments To Acquire Non Marketable Equity Investments
PaymentsToAcquireNonMarketableEquityInvestments
1000000
CY2020Q1 us-gaap Payments For Software
PaymentsForSoftware
4068000
CY2020Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1010000
CY2021Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-9660000
CY2020Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-19904000
CY2021Q1 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
399000
CY2020Q1 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
373000
CY2020Q1 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
9876000
CY2021Q1 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
12000
CY2020Q1 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
30000
CY2021Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-411000
CY2020Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
107425000
CY2021Q1 hstm Sales Commissions Amortization Term Description
SalesCommissionsAmortizationTermDescription
Non-commensurate commissions are amortized over the greater of the contract term or technological obsolescence period of approximately three years.
CY2021Q1 hstm Sales Commissions Amortization Period
SalesCommissionsAmortizationPeriod
P3Y
CY2021Q1 us-gaap Amortization Of Deferred Sales Commissions
AmortizationOfDeferredSalesCommissions
2100000
CY2020Q1 us-gaap Amortization Of Deferred Sales Commissions
AmortizationOfDeferredSalesCommissions
2200000
CY2021Q1 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
55974000
CY2021Q1 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
4000
CY2021Q1 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
55970000
CY2020Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
32334000
CY2021Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
900000
CY2020Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1900000
CY2021Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.29
CY2020Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.21
CY2021Q1 us-gaap Income Tax Reconciliation Change In Enacted Tax Rate
IncomeTaxReconciliationChangeInEnactedTaxRate
100000
CY2021Q1 hstm Additional Income Tax Expense For Tax Deficiencies Associated With Stock Based Awards
AdditionalIncomeTaxExpenseForTaxDeficienciesAssociatedWithStockBasedAwards
17000
CY2020Q1 hstm Additional Income Tax Expense For Tax Deficiencies Associated With Stock Based Awards
AdditionalIncomeTaxExpenseForTaxDeficienciesAssociatedWithStockBasedAwards
26000
CY2021Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
616000
CY2020Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
550000
CY2020Q1 us-gaap Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
30000000.0
CY2020Q1 us-gaap Stock Repurchase Program Expiration Date
StockRepurchaseProgramExpirationDate
2021-03-12
CY2020Q1 us-gaap Stock Repurchased During Period Shares
StockRepurchasedDuringPeriodShares
957367
CY2020Q1 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
20000000.0
CY2020Q1 hstm Stock Repurchased Average Price Per Share
StockRepurchasedAveragePricePerShare
20.89
CY2021Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
148000
CY2020Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
106000
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
2291000
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
7092000
CY2021Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
31504000
CY2021Q1 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
22000
CY2020Q1 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
23000
CY2021Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
31526000
CY2020Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
32357000
CY2021Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.07
CY2020Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.22
CY2021Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.07
CY2020Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.22
CY2021Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
3300000
CY2020Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
7244000
CY2020Q4 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
46502000
CY2020Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
61572000
CY2021Q1 us-gaap Cash And Cash Equivalents Fair Value Disclosure
CashAndCashEquivalentsFairValueDisclosure
45348000
CY2021Q1 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
10622000
CY2020Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
8000
CY2020Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
46494000
CY2020Q4 us-gaap Cash And Cash Equivalents Fair Value Disclosure
CashAndCashEquivalentsFairValueDisclosure
36566000
CY2020Q4 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
9928000
CY2021Q1 us-gaap Debt Securities Available For Sale Allowance For Credit Loss
DebtSecuritiesAvailableForSaleAllowanceForCreditLoss
0
CY2020Q4 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Intangibles
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles
12660000
CY2021Q1 us-gaap Goodwill Period Increase Decrease
GoodwillPeriodIncreaseDecrease
2700000
CY2021Q1 us-gaap Goodwill Acquired During Period
GoodwillAcquiredDuringPeriod
600000
CY2021Q1 us-gaap Goodwill Foreign Currency Translation Gain Loss
GoodwillForeignCurrencyTranslationGainLoss
400000
CY2021Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
63468000
CY2021Q1 us-gaap Assets
Assets
501682000
CY2020Q4 us-gaap Assets
Assets
500313000
CY2021Q1 us-gaap Equity Securities Without Readily Determinable Fair Value Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueAmount
3900000
CY2020Q4 us-gaap Equity Securities Without Readily Determinable Fair Value Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueAmount
3900000
CY2021Q1 hstm Gain On Non Marketable Equity Investments
GainOnNonMarketableEquityInvestments
100000
CY2018 hstm Change In Fair Value Of Non Marketable Equity Investments
ChangeInFairValueOfNonMarketableEquityInvestments
1300000

Files In Submission

Name View Source Status
0001564590-21-022023-index-headers.html Edgar Link pending
0001564590-21-022023-index.html Edgar Link pending
0001564590-21-022023.txt Edgar Link pending
0001564590-21-022023-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
hstm-10q_20210331.htm Edgar Link pending
hstm-10q_20210331_htm.xml Edgar Link completed
hstm-20210331.xsd Edgar Link pending
hstm-20210331_cal.xml Edgar Link unprocessable
hstm-20210331_def.xml Edgar Link unprocessable
hstm-20210331_lab.xml Edgar Link unprocessable
hstm-20210331_pre.xml Edgar Link unprocessable
hstm-ex1018_10.htm Edgar Link pending
hstm-ex1019_11.htm Edgar Link pending
hstm-ex1020_140.htm Edgar Link pending
hstm-ex311_9.htm Edgar Link pending
hstm-ex312_6.htm Edgar Link pending
hstm-ex321_7.htm Edgar Link pending
hstm-ex322_8.htm Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending